Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,626 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- OncoTree
- BREAST
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01331629 | Impact of Art Therapy on Fatigue and Quality of Life of Patients Treated With Adjuvant Radiotherapy for Breast Cancer(ART-THERAPIE) | completed | Phase 2 / Phase 3 | 322 | Centre Francois BaclesseOTHER | 1 | Mar 14, 2017 | clinicaltrials |
| NCT01572727 | A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation(BELLE-4) | completed | Phase 2 / Phase 3 | 416 | Novartis Pharmaceuticals |
| 22 |
| Mar 9, 2017 |
| clinicaltrials |
| NCT01762020 | Barrier Film vs. Standard Skin Care in Preventing Dermatitis in Women With Breast Cancer Receiving Radiation | completed | Phase 3 | 56 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Mar 8, 2017 | clinicaltrials |
| NCT02144012 | A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine Versus the Combination of Trastuzumab Plus Docetaxel in Patients With HER2-positive Breast Cancer | terminated | Phase 3 | 49 | Hoffmann-La RocheINDUSTRY | 4 | Mar 7, 2017 | clinicaltrials |
| NCT00329940 | Safety and Rheumatologic Tolerability of Letrozole in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer | completed | Phase 3 | 200 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 24, 2017 | clinicaltrials |
| NCT00332852 | Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer | completed | Phase 3 | 655 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 23, 2017 | clinicaltrials |
| NCT01626222 | 4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer(MACS2096) | completed | Phase 3 | 301 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 23, 2017 | clinicaltrials |
| NCT00330317 | Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer | completed | Phase 3 | 300 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 7, 2017 | clinicaltrials |
| NCT00695916 | MRI in Women With Newly Diagnosed Breast Cancer Prior to Breast Conserving Surgery | withdrawn | Phase 3 | 0 | Stanford UniversityOTHER | 0 | Feb 1, 2017 | clinicaltrials |
| NCT00156806 | Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing Cutaneous Side-Effects of Radiation Treatment for Breast Cancer. | completed | Phase 3 | 231 | AHS Cancer Control AlbertaOTHER | 1 | Jan 24, 2017 | clinicaltrials |
| NCT03006614 | PERS Genetic Model Assistant Decision-making System of Neoadjuvant Chemotherapy for Breast Cancer(PERS) | unknown | Phase 3 | 320 | Shi YanxiaOTHER | 1 | Jan 16, 2017 | clinicaltrials |
| NCT02213744 | MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients(HERMIONE) | terminated | Phase 2 / Phase 3 | 113 | Merrimack PharmaceuticalsINDUSTRY | 9 | Jan 6, 2017 | clinicaltrials |
| NCT01708798 | Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer | terminated | Phase 2 / Phase 3 | 44 | University of British ColumbiaOTHER | 1 | Jan 5, 2017 | clinicaltrials |
| NCT02609321 | Efficacy of Thoracic Paravertebral Block in the Reduction of Acute Post-surgical Pain in Patients With Breast Cancer | completed | Phase 3 | 60 | Instituto de Cancerología S.A.OTHER | 1 | Dec 26, 2016 | clinicaltrials |
| NCT00363909 | Citalopram in Treating Postmenopausal Women With Hot Flashes | completed | Phase 3 | 254 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 13, 2016 | clinicaltrials |
| NCT01986569 | Diagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer | completed | Phase 3 | 93 | Asan Medical CenterOTHER | 1 | Dec 8, 2016 | clinicaltrials |
| NCT00107263 | Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer | completed | Phase 3 | 558 | Alliance for Clinical Trials in OncologyOTHER | 0 | Dec 6, 2016 | clinicaltrials |
| NCT00912444 | Neoadjuvant Treatment of Docetaxel, Anthracycline and Cyclophosphamide (TAC) Versus Docetaxel and Cyclophosphamide (TC) in Triple-Negative or Her2 Positive Breast Cancer(NATT) | terminated | Phase 3 | 102 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Nov 22, 2016 | clinicaltrials |
| NCT02958033 | Shandong Cancer Hospital Affiliated to Shandong University | unknown | Phase 3 | 100 | Shandong Cancer Hospital and InstituteOTHER | 1 | Nov 8, 2016 | clinicaltrials |
| NCT00661102 | A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine). | completed | Phase 3 | 598 | Hoffmann-La RocheINDUSTRY | 1 | Nov 2, 2016 | clinicaltrials |
| NCT00829166 | A Study of Trastuzumab Emtansine Versus Capecitabine + Lapatinib in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer(EMILIA) | completed | Phase 3 | 991 | Hoffmann-La RocheINDUSTRY | 27 | Oct 31, 2016 | clinicaltrials |
| NCT00066807 | Premenopausal Endocrine Responsive Chemotherapy Trial(PERCHE) | terminated | Phase 3 | 29 | ETOP IBCSG Partners FoundationNETWORK | 3 | Oct 28, 2016 | clinicaltrials |
| NCT01419197 | A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed Therapy(TH3RESA) | completed | Phase 3 | 602 | Hoffmann-La RocheINDUSTRY | 22 | Oct 12, 2016 | clinicaltrials |
| NCT02830685 | Pre-pectoral Breast Reconstruction PART 1(PreBRec) | unknown | Phase 3 | 131 | Guy's and St Thomas' NHS Foundation TrustOTHER | 1 | Oct 3, 2016 | clinicaltrials |
| NCT02831426 | Pre-pectoral Breast Reconstruction PART 2(PreBRec) | unknown | Phase 3 | 86 | Guy's and St Thomas' NHS Foundation TrustOTHER | 1 | Oct 3, 2016 | clinicaltrials |
| NCT00022516 | Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer(22-00) | completed | Phase 3 | 1,086 | ETOP IBCSG Partners FoundationNETWORK | 11 | Sep 16, 2016 | clinicaltrials |
| NCT01246427 | Evaluation of Homeopathic Treatment for Hot Flashes in Non Metastatic Breast Cancer(HBC) | completed | Phase 3 | 138 | Centre Leon BerardOTHER | 1 | Sep 14, 2016 | clinicaltrials |
| NCT00190489 | A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Cancer | completed | Phase 3 | 450 | Japan Clinical Oncology GroupOTHER | 1 | Sep 2, 2016 | clinicaltrials |
| NCT00868634 | Capecitabine and Bevacizumab ± Vinorelbine in Metastatic Breast Cancer(CARIN) | completed | Phase 3 | 600 | iOMEDICO AGINDUSTRY | 1 | Aug 31, 2016 | clinicaltrials |
| NCT00357734 | Iressa Follow-up Trial | completed | Phase 3 | 14 | AstraZenecaINDUSTRY | 1 | Aug 30, 2016 | clinicaltrials |
| NCT01413828 | Trastuzumab Administered Concurrently or Sequentially to Anthracycline-containing Adjuvant Regimen for Breast Cancer | completed | Phase 2 / Phase 3 | 201 | Peking Union Medical College HospitalOTHER | 1 | Aug 17, 2016 | clinicaltrials |
| NCT00024102 | Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer | completed | Phase 3 | 633 | Alliance for Clinical Trials in OncologyOTHER | 3 | Aug 12, 2016 | clinicaltrials |
| NCT00343382 | Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer | completed | Phase 3 | 201 | Alliance for Clinical Trials in OncologyOTHER | 1 | Aug 12, 2016 | clinicaltrials |
| NCT00692458 | A Study to Assess the Effects of MK0822 in Reducing the Risk of Bone Metastasis in Women With Breast Cancer (0822-029) | withdrawn | Phase 3 | 0 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Aug 12, 2016 | clinicaltrials |
| NCT02865304 | The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC Patients | unknown | Phase 3 | 80 | Fujian Cancer HospitalOTHER_GOV | 0 | Aug 12, 2016 | clinicaltrials |
| NCT02104895 | Accelerated Partial Breast Irradiation Using Intensity Modulated Radiotherapy Versus Whole Breast Irradiation | completed | Phase 3 | 520 | Azienda Ospedaliero-Universitaria CareggiOTHER | 0 | Aug 11, 2016 | clinicaltrials |
| NCT00805597 | Clinical Trial of Postmastectomy Radiotherapy in Breast Cancer With One to Three Positive Nodes | terminated | Phase 3 | 40 | Chinese Academy of Medical SciencesOTHER | 1 | Aug 8, 2016 | clinicaltrials |
| NCT01568346 | Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy | terminated | Phase 3 | 9 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 2, 2016 | clinicaltrials |
| NCT00438659 | Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ | completed | Phase 3 | 176 | North Central Cancer Treatment GroupNETWORK | 1 | Aug 1, 2016 | clinicaltrials |
| NCT00702949 | Pregabalin in Treating Women With Hot Flashes | completed | Phase 3 | 207 | Alliance for Clinical Trials in OncologyOTHER | 1 | Aug 1, 2016 | clinicaltrials |
| NCT00293540 | Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer | completed | Phase 3 | 249 | International Breast Cancer Research FoundationOTHER | 10 | Jul 27, 2016 | clinicaltrials |
| NCT00659373 | Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02(Co-SOFT) | completed | Phase 3 | 86 | ETOP IBCSG Partners FoundationNETWORK | 2 | Jul 25, 2016 | clinicaltrials |
| NCT00022087 | Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer | completed | Phase 3 | 439 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 19, 2016 | clinicaltrials |
| NCT00249015 | Trial of Combined Aerobic and Resistance Exercise in Breast Cancer Survivors | completed | Phase 3 | 301 | AHS Cancer Control AlbertaOTHER | 1 | Jul 18, 2016 | clinicaltrials |
| NCT00087399 | Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy | completed | Phase 3 | 118 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 14, 2016 | clinicaltrials |
| NCT00003600 | Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy | completed | Phase 3 | 344 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 13, 2016 | clinicaltrials |
| NCT00003674 | Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer | completed | Phase 3 | 141 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 13, 2016 | clinicaltrials |
| NCT00003854 | Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer | completed | Phase 3 | 4,590 | Alliance for Clinical Trials in OncologyOTHER | 3 | Jul 13, 2016 | clinicaltrials |
| NCT00026117 | Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer | completed | Phase 3 | 88 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 13, 2016 | clinicaltrials |
| NCT00054418 | Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer | completed | Phase 3 | 216 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 13, 2016 | clinicaltrials |
Data updated 24 days agoSource updated Mar 14, 2017source: clinicaltrials